Diallyl Disulfide Mitigates Cadmium Hepatotoxicity by Attenuating Oxidative Stress and TLR-4/NF-κB Signaling and Upregulating PPARγ

• Published in: Frontiers in bioscience (Landmark. Print) 2024-10, Vol.29 (10), p.369
• Main Authors: Alruhaimi, Reem S, Hassanein, Emad H M, Alotaibi, Mohammed F, Alzoghaibi, Mohammed A, Abd El-Ghafar, Omnia A M, Mohammad, Mostafa K, Alnasser, Sulaiman M, Mahmoud, Ayman M
• Format: Article
• Language: English
• Subjects: Allyl Compounds - pharmacology; Animals; Antioxidants - metabolism; Antioxidants - pharmacology; Cadmium - toxicity; Chemical and Drug Induced Liver Injury - drug therapy; Chemical and Drug Induced Liver Injury - metabolism; Chemical and Drug Induced Liver Injury - prevention & control; diallyl disulfide; Disulfides - pharmacology; garlic; heavy metals; hepatotoxicity; inflammation; Liver - drug effects; Liver - metabolism; Liver - pathology; Male; NF-kappa B - metabolism; oxidative stress; Oxidative Stress - drug effects; PPAR gamma - metabolism; Rats; Rats, Wistar; Signal Transduction - drug effects; Toll-Like Receptor 4 - metabolism; Up-Regulation - drug effects
• ISSN: 2768-6701; 2768-6698; 2768-6698
• DOI: 10.31083/j.fbl2910369

Heavy metals can cause serious health problems that affect different organs. Cadmium (Cd) is an environmental contaminant known for its toxicological consequences on different organs. Hepatotoxicity is a serious effect of exposure to Cd with oxidative stress (OS) and inflammation playing a central role. Diallyl disulfide (DADS), an organo-sulfur compound found in garlic, is known for its cytoprotective and antioxidant effects. In this study, the effect of DADS on Cd-induced inflammation, oxidative stress and liver injury was investigated. DADS was supplemented for 14 days via oral gavage, and a single intraperitoneal dose of Cd (1.2 mg/kg body weight) was administered to rats on day 7. Blood and liver samples were collected at the end of the experiment for analyses. Cd administration resulted in remarkable hepatic dysfunction, degenerative changes, necrosis, infiltration of inflammatory cells, collagen deposition and other histopathological alterations. Cd increased liver malondialdehyde (MDA) and nitric oxide (NO) ( < 0.001), upregulated toll-like receptor (TLR)-4, nuclear factor-kappaB (NF-κB), pro-inflammatory mediators, and caspase-3 ( < 0.001) whereas decreased glutathione (GSH) and antioxidant enzymes ( < 0.001). Cd downregulated peroxisome proliferator activated receptor gamma (PPARγ), a transcription factor involved in inflammation and OS suppression ( < 0.001). DADS ameliorated liver injury and tissue alterations, attenuated OS and apoptosis, suppressed TLR-4/NF-κB signaling, and enhanced antioxidants. In addition, DADS upregulated PPARγ in the liver of Cd-administered rats. DADS is effective against Cd-induced hepatotoxicity and its beneficial effects are linked to suppression of inflammation, OS and apoptosis and upregulation of PPARγ. DADS could be valuable to protect the liver in individuals at risk of Cd exposure, pending further studies to elucidate other underlying mechanism(s).